Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study. [electronic resource]
- Alimentary pharmacology & therapeutics 07 2018
- 35-43 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't